发明名称 Low affinity FCGR deficient mice
摘要 Genetically modified non-human animals and methods and compositions for making and using them are provided, wherein the genetic modification comprises a deletion of the endogenous low affinity FcγR locus, and wherein the mouse is capable of expressing a functional FcRγ-chain. Genetically modified mice are described, including mice that express low affinity human FcγR genes from the endogenous FcγR locus, and wherein the mice comprise a functional FcRγ-chain. Genetically modified mice that express up to five low affinity human FcγR genes on accessory cells of the host immune system are provided.
申请公布号 US9089599(B2) 申请公布日期 2015.07.28
申请号 US201414152106 申请日期 2014.01.10
申请人 Regeneron Pharmaceuticals, Inc. 发明人 Macdonald Lynn;Tu Naxin;Gurer Cagan;Stevens Sean;Murphy Andrew J.
分类号 A61K49/00;A01K67/027;C07K14/735;G01N33/50 主分类号 A61K49/00
代理机构 Foley Hoag LLP 代理人 Jones Brendan T.;Miyamoto Neil;Foley Hoag LLP
主权项 1. A transgenic mouse whose genome comprises a homozygous disruption in an endogenous FcγRIIB α-chain gene, a homozygous disruption in an endogenous FcγRIV α-chain gene, a homozygous disruption in an endogenous FcγRIII α-chain gene, and a nucleic acid sequence encoding a human CD20 gene, wherein the mouse specifically expresses functional CD20 on B cells.
地址 Tarrytown NY US